ORDER denying without prejudice (22) Letter Motion for Discovery in case 1:16-mc-07000-WHP; denying without prejudice (80) Letter Motion for Discovery in case 1:16-mc-07229-WHP; denying without prejudice (77) Letter Motion for Discovery in case 1:16-mc-07987-WHP; denying without prejudice (66) Letter Motion for Discovery in case 1:16-mc-08911-WHP. Application denied without prejudice in deference to a similar application pending before the conditional transferee court in the Eastern District of Pennsylvania. Nevertheless, Defendants' discovery obligations under this Court's Order are adjourned pending a determination by the transferee judge. (Signed by Judge William H. Pauley, III on 4/12/2017) Filed In Associated Cases: 1:16-mc-07000-WHP, 1:16-mc-07229-WHP, 1:16-mc-07987-WHP, 1:16-mc-08911-WHP (cla) (Entered: 04/12/2017)
LETTER addressed to Judge William H. Pauley, III from Daniel C. Girard dated April 11, 2017 re: Response to Defendants April 10, 2017 letter. Document filed by Sergeants Benevolent Association Health & Welfare Fund.(Girard, Daniel) (Entered: 04/11/2017)
LETTER MOTION for Discovery Obligations. Defendants Respecfully Request that this Court Suspend the Parties Current Discovery Obligations. addressed to Judge William H. Pauley, III from Christopher T. Holding dated April 10, 2017. Document filed by Actavis Holdco U.S., Inc., Akorn, Inc., Fougera Pharmaceuticals, Inc., Hi-Tech Pharmacal Co., Inc., Morton Grove Pharmaceuticals, Inc., Perrigo New York, Inc., Sandoz, Inc., Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals USA, Inc., Wockhardt USA LLC. (Attachments: # 1 Exhibit A-Transfer Order, # 2 Exhibit B-Conditional Transfer Order)(Holding, Christopher) (Entered: 04/11/2017)
NOTICE OF FILING OF OFFICIAL TRANSCRIPT Notice is hereby given that an official transcript of a CONFERENCE proceeding held on 3/21/17 has been filed by the court reporter/transcriber in the above-captioned matter. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely electronically available to the public without redaction after 90 calendar days...Filed In Associated Cases: 1:16-mc-07000-WHP et al.(McGuirk, Kelly) (Entered: 04/03/2017)
TRANSCRIPT of Proceedings re: CONFERENCE held on 3/21/2017 before Judge William H. Pauley, III. Court Reporter/Transcriber: Lisa Picciano Fellis, (212) 805-0300. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 4/24/2017. Redacted Transcript Deadline set for 5/4/2017. Release of Transcript Restriction set for 7/3/2017.Filed In Associated Cases: 1:16-mc-07000-WHP et al.(McGuirk, Kelly) (Entered: 04/03/2017)
MASTER CASE ORDER No. 7 (Discovery Stay Order) granting in part and denying in part (58) Motion to Stay ; granting in part and denying in part (59) Motion to Stay in case 1:16-mc-07229-WHP; granting in part and denying in part (51) Motion to Stay ; granting in part and denying in part (52) Motion to Stay in case 1:16-mc-07987-WHP; granting in part and denying in part (44) Motion to Stay ; granting in part and denying in part (45) Motion to Stay in case 1:16-mc-08911-WHP. Accordingly, Defendants' motion to stay is granted with regard to deposition discovery, but denied in all other respects. (Signed by Judge William H. Pauley, III on 3/27/2017) Filed In Associated Cases: 1:16-mc-07000-WHP, 1:16-mc-07229-WHP, 1:16-mc-07987-WHP, 1:16-mc-08911-WHP (cla) (Entered: 03/27/2017)
MASTER CASE ORDER No. 6 (Motion Briefing Schedule): The parties having appeared for a conference on March 21, 2017, the following schedule for the motions to dismiss is entered on consent: (1) Defendants shall file their motions to dismiss by May 5, 2017; (2) Plaintiffs shall file their opposition by May 26, 2017; (3) Any replies shall be filed by June 5, 2017; and (4) The parties shall appear for oral argument on June 22, 2017 at 3:00 p.m. (Motions due by 5/5/2017., Responses due by 5/26/2017, Replies due by 6/5/2017., Oral Argument set for 6/22/2017 at 03:00 PM before Judge William H. Pauley III.) (Signed by Judge William H. Pauley, III on 3/24/2017) Filed In Associated Cases: 1:16-mc-07000-WHP, 1:16-mc-07229-WHP, 1:16-mc-07987-WHP, 1:16-mc-08911-WHP(cla) (Entered: 03/24/2017)
MEMO ENDORSEMENT on re: (55 in 1:16-mc-08911-WHP) Letter re: Agreements Between DOJ and Plaintiffs Concerning Conduct of Discovery, filed by Sergeants Benevolent Association Health & Welfare Fund, (68 in 1:16-mc-07229-WHP) Letter re: Agreements Between DOJ and Plaintiffs Concerning Conduct of Discovery, filed by Sergeants Benevolent Association Health & Welfare Fund, (63 in 1:16-mc-07987-WHP) Letter re: Agreements Between DOJ and Plaintiffs Concerning Conduct of Discovery, filed by Sergeants Benevolent Association Health & Welfare Fund. ENDORSEMENT: Application granted. (Signed by Judge William H. Pauley, III on 3/22/2017) Filed In Associated Cases: 1:16-mc-07000-WHP, 1:16-mc-07229-WHP, 1:16-mc-07987-WHP, 1:16-mc-08911-WHP(cla) (Entered: 03/22/2017)
MEMO ENDORSEMENT on re: 72 Letter re: Removal of Actavis Holdco U.S., Inc. From List of Parties filed by Actavis Holdco U.S., Inc. ENDORSEMENT: Application granted. The Clerk of Court is directed to remove Actavis Holdco U.S., Inc. from docket 16mc7229. (Actavis Holdco U.S., Inc. terminated.) (Signed by Judge William H. Pauley, III on 3/16/2017) (cla) (Entered: 03/16/2017)
LETTER addressed to Judge William H. Pauley, III from Christopher T. Holding dated March 15, 2017 re: Removal of Actavis Holdco U.S., Inc. From List of Parties. Document filed by Actavis Holdco U.S., Inc..(Holding, Christopher) (Entered: 03/15/2017)
MEMO ENDORSEMENT: on re: (13 in 1:16-mc-07000-WHP) Letter filed by Sandoz, Inc., Taro Pharmaceutical Industries Ltd., Actavis Holdco U.S., Inc., Taro Pharmaceuticals USA, Inc., Fougera Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc. ENDORSEMENT: Application granted.The Clerk of Court is directed to remove the below referenced Defendants from dockets 16mc7000, 16mc7229, 16mc7987,and 16mc8911. SO ORDERED. (Signed by Judge William H. Pauley, III on 3/13/2017) (ama) (Entered: 03/15/2017)
REPLY MEMORANDUM OF LAW in Support re: 59 MOTION to Stay Discovery. (Filing Fee $ 46.00.), 58 LETTER MOTION to Stay addressed to Judge William H. Pauley, III from Andrew J. Ewalt dated February 28, 2017. (Filing Fee $ 46.00.) . Document filed by Akorn, Inc., Fougera Pharmaceuticals, Inc., Hi-Tech Pharmacal Co., Inc., Morton Grove Pharmaceuticals, Inc., Perrigo New York, Inc., Sandoz, Inc., Taro Pharmaceuticals USA, Inc., Wockhardt USA LLC. (Attachments: # 1 Attachment A (ECF Technical Error Statement))(Serino, Joseph) (Entered: 03/11/2017)
LETTER addressed to Judge William H. Pauley, III from End Payor and Direct Purchaser Plaintiffs dated March 10, 2017 re: Defendants March 3, 2017 letter. Document filed by Sergeants Benevolent Association Health & Welfare Fund.(Girard, Daniel) (Entered: 03/10/2017)
LETTER addressed to Judge William H. Pauley, III from Daniel C. Girard dated March 10, 2017 re: Agreements Between DOJ and Plaintiffs Concerning Conduct of Discovery. Document filed by Sergeants Benevolent Association Health & Welfare Fund.(Girard, Daniel) (Entered: 03/10/2017)
MEMO ENDORSEMENT on re: (49 in 1:16-mc-08911-WHP) Letter filed by Sergeants Benevolent Association Health & Welfare Fund, (57 in 1:16-mc-07987-WHP) Letter filed by Sergeants Benevolent Association Health & Welfare Fund, (63 in 1:16-mc-07229-WHP) Letter filed by Sergeants Benevolent Association Health & Welfare Fund. ENDORSEMENT: Application granted. The oral argument scheduled for March 15, 2017 is rescheduled to March 21, 2017 at 11:00 a.m. (Oral Argument set for 3/21/2017 at 11:00 AM before Judge William H. Pauley III.) (Signed by Judge William H. Pauley, III on 3/9/2017) Filed In Associated Cases: 1:16-mc-07000-WHP et al.(cla) (Entered: 03/09/2017)
DECLARATION of Daniel C. Girard in Opposition re: 59 MOTION to Stay Discovery. (Filing Fee $ 46.00.). Document filed by Sergeants Benevolent Association Health & Welfare Fund. (Attachments: # 1 Exhibit 1)(Girard, Daniel) (Entered: 03/07/2017)
JOINT MEMORANDUM OF LAW in Opposition re: 59 MOTION to Stay Discovery. (Filing Fee $ 46.00.) . Document filed by Sergeants Benevolent Association Health & Welfare Fund. (Girard, Daniel) (Entered: 03/07/2017)
LETTER addressed to Judge William H. Pauley, III from Daniel C. Girard dated March 7, 2017 re: Response to Letters Dated February 23, 2017 and March 1, 2017. Document filed by Sergeants Benevolent Association Health & Welfare Fund.(Girard, Daniel) (Entered: 03/07/2017)
LETTER addressed to Judge William H. Pauley, III from All Parties dated March 7, 2017 re: Schedule for Oral Argument. Document filed by Sergeants Benevolent Association Health & Welfare Fund.(Girard, Daniel) (Entered: 03/07/2017)
JOINT LETTER MOTION for Conference requesting a pre-motion conference regarding motions to dismiss the direct and indirect purchaser consolidated amended complaints addressed to Judge William H. Pauley, III dated March 3, 2017. Document filed by Akorn, Inc., Fougera Pharmaceuticals, Inc., Hi-Tech Pharmacal Co., Inc., Morton Grove Pharmaceuticals, Inc., Perrigo New York, Inc., Sandoz, Inc., Taro Pharmaceuticals USA, Inc., Wockhardt USA LLC.(Serino, Joseph) (Entered: 03/03/2017)
MASTER CASE ORDER NO. 5 denying as moot (31 in case 1:16-mc-07229-WHP) Motion to Seal Document; denying as moot (32 in case 1:16-mc-07229-WHP) Motion for Leave to File Consolidated Amended Complaint Under Seal; denying as moot (26 in case 1:16-mc-07987-WHP) Motion to Seal; denying as moot (27 in case 1:16-mc-07987-WHP) Motion for Leave to File Consolidated Amended Complaint Under Seal; denying as moot (25 in case 1:16-mc-08911-WHP) Motion to Seal Document; denying as moot (26 in case 1:16-mc-08911-WHP) Motion for Leave to File Consolidated Amended Complaint Under Seal. Accordingly, End Payor Plaintiffs and Direct Purchasers' motions for leave to file under seal are hereby denied as moot. (Signed by Judge William H. Pauley, III on 3/3/2017) Filed In Associated Cases: 1:16-mc-07000-WHP et al. (cla) Modified on 3/6/2017 (cla). (Entered: 03/03/2017)
MEMORANDUM OF LAW in Support re: 59 MOTION to Stay Discovery. (Filing Fee $ 46.00.) . Document filed by Akorn, Inc., Fougera Pharmaceuticals, Inc., Hi-Tech Pharmacal Co., Inc., Morton Grove Pharmaceuticals, Inc., Perrigo New York, Inc., Sandoz, Inc., Taro Pharmaceuticals USA, Inc., Wockhardt USA LLC. (Serino, Joseph) (Entered: 02/28/2017)
LETTER MOTION to Stay addressed to Judge William H. Pauley, III from Andrew J. Ewalt dated February 28, 2017. (Filing Fee $ 46.00.) Document filed by United States of America.(Ewalt, Andrew) (Entered: 02/28/2017)
NOTICE OF APPEARANCE by Andrew Ewalt on behalf of United States of America. Filed In Associated Cases: 1:16-mc-07229-WHP et al.(Ewalt, Andrew) (Entered: 02/28/2017)
CERTIFICATE OF SERVICE of End Payor Plaintiffs Consolidated Amended Complaint served on Arizona Attorney General on February 24, 2017. Service was made by Mail. Document filed by Sergeants Benevolent Association Health & Welfare Fund. (Girard, Daniel) (Entered: 02/27/2017)
NOTICE OF CHANGE OF ADDRESS by Lisa Jose Fales on behalf of Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals USA, Inc.. New Address: Venable LLP, 600 Massachusetts Avenue, NW, Washington, d, USA 20001, 202-344-4349. (Fales, Lisa) (Entered: 02/27/2017)
NOTICE OF CHANGE OF ADDRESS by Danielle Foley on behalf of Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals USA, Inc.. New Address: Venable LLP, 600 Massachusetts Avenue, NW, Washington, DC, USA 20001, 202-344-4343. (Foley, Danielle) (Entered: 02/27/2017)
NOTICE OF CHANGE OF ADDRESS by James Douglas Baldridge on behalf of Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals USA, Inc.. New Address: Venable LLP, 600 Massachusetts Avenue, NW, Washington, DC, USA 20001, 202-344-4703. (Baldridge, James) (Entered: 02/27/2017)
AMENDED COMPLAINT against Akorn, Inc., Fougera Pharmaceuticals, Inc., Hi-Tech Pharmacal Co., Inc., Morton Grove Pharmaceuticals, Inc., Sandoz, Inc., Taro Pharmaceuticals USA, Inc., Wockhardt USA LLC with JURY DEMAND.Document filed by UFCW Local 1500 Welfare Fund, United Food and Commercial Workers Unions and Employers Midwest Health Benefits Fund, Sergeants Benevolent Association Health & Welfare Fund, International Union of Operating Engineers Local 30 Benefits Fund, St. Paul Electrical Workers' Health Plan.(Girard, Daniel) (Entered: 02/24/2017)
STIPULATION AND ORDER. IT IS HEREBY STIPULATED AND AGREED by and between Plaintiffs and Taro 1. The U.S. Government is permitted to intervene in the above-captioned matters under Federal Rule of Civil Procedure 24 with respect to the Court's order in Master Case Order No. 1 that Taro produce subpoenas and related communications. 2. The time for Taro to produce the subpoenas and related communications under Master Case Order No. 1 is extended to March 31, 2017. So ordered. (Signed by Judge William H. Pauley, III on 2/22/2017) Filed In Associated Cases: 1:16-mc-07000-WHP et al. and entered in case no. 17cv964, as per Chambers request. (rjm). (Entered: 02/23/2017)
DECLARATION of Adam E. Polk in Support re: 49 Brief. Document filed by Sergeants Benevolent Association Health & Welfare Fund. (Girard, Daniel) (Entered: 02/22/2017)
BRIEF re: 42 Order,, (Master Case Order No. 3). Document filed by Sergeants Benevolent Association Health & Welfare Fund.(Girard, Daniel) (Entered: 02/22/2017)
AMENDED COMPLAINT against Akorn, Inc., Fougera Pharmaceuticals, Inc., Hi-Tech Pharmacal Co., Inc., Morton Grove Pharmaceuticals, Inc., Perrigo New York, Inc., Sandoz, Inc., Taro Pharmaceuticals USA, Inc., Wockhardt USA LLC with JURY DEMAND.Document filed by Cesar Castillo, Inc., FWK Holdings, L.L.C..(Kaplan, Robert) (Entered: 02/22/2017)
BRIEF DIRECT PURCHASER PLAINTIFFS' MEMORANDUM IN RESPONSE TO MASTER CASE ORDER NO. 3. Document filed by Cesar Castillo, Inc., FWK Holdings, L.L.C..(Kaplan, Robert) (Entered: 02/22/2017)
MASTER CASE ORDER No. 4: By letter dated February 10, 2017, Defendants request a pre-motion conference to discuss a motion to stay discovery in this action. Plaintiffs oppose the application by letter dated February 17, 2017. This Court finds that a pre-motion conference can be obviated by an accelerated briefing schedule on the proposed motion. Accordingly, Defendants may file their motion to stay discovery by February 28, 2017. Any opposition should be filed by March 7, 2017. Any reply should be filed by March 10, 2017. The parties are directed to appear for an oral argument on March 15, 2017 at 12:00 p.m. The time to respond to Plaintiffs' discovery requests is stayed pending the oral argument. (Motions due by 2/28/2017., Responses due by 3/7/2017, Replies due by 3/10/2017., Oral Argument set for 3/15/2017 at 12:00 PM before Judge William H. Pauley III.) (Signed by Judge William H. Pauley, III on 2/22/2017) Filed In Associated Cases: 1:16-mc-07000-WHP et al.(cla) (Entered: 02/22/2017)
LETTER addressed to Judge William H. Pauley, III from Daniel C. Girard dated February 17, 2017 re: Response to Defendants' February 10, 2017. Document filed by Sergeants Benevolent Association Health & Welfare Fund.(Girard, Daniel) (Entered: 02/17/2017)
NOTICE OF VOLUNTARY DISMISSAL WITHOUT PREJUDICE: PLEASE TAKE NOTICE that plaintiff NECA-IBEW Welfare Trust Fund, by and through its undersigned counsel and in accordance with Fed. R. Civ. P. 41(a)(1)(A)(i), hereby voluntarily dismisses without prejudice its complaint in the action styled NECA-IBEW Welfare Trust Fund v. Akorn, Inc., No. 1:16-cv-08109-WHP (S.D.N.Y.). No defendant in this action has answered or filed for summary judgment, and a class has not been certified in this action. (Signed by Judge William H. Pauley, III on 2/16/2017) Filed In Associated Cases: 1:16-mc-07229-WHP, 1:16-cv-08109-WHP(cla) (Entered: 02/16/2017)
MASTER CASE ORDER NO. 3: By motions dated February 10, 2017, the End Payor Plaintffs and the Direct Purchaser Plaintiffs seek leave to file their consolidated amended complaints under seal. On February 13, 2017, this Court received redacted consolidated amended complaints, which Plaintiffs propose be filed publicly. Accordingly, counsel are directed to submit memoranda by February 22, 2017 explaining the reasons for any proposed redactions. (Signed by Judge William H. Pauley, III on 2/15/2017) Filed In Associated Cases: 1:16-mc-07000-WHP et al, as per chambers.(cla) (Entered: 02/15/2017)
STIPULATED INTERIM PROTECTIVE ORDER CONCERNING PROTECTED INFORMATION FOR USE IN PLAINTIFFS' CONSOLIDATED AMENDED COMPLAINTS...regarding procedures to be followed that shall govern the handling of confidential material... (Signed by Judge William H. Pauley, III on 2/10/2017) (mro) (Entered: 02/13/2017)
STIPULATED INTERIM PROTECTIVE ORDER CONCERNING PROTECTED INFORMATION FOR USE IN PLAINTIFFS' CONSOLIDATED AMENDED COMPLAINTS...regarding procedures to be followed that shall govern the handling of confidential material... (Signed by Judge William H. Pauley, III on 2/10/2017) Filed In Associated Cases: 1:16-mc-07000-WHP et al, as per Chambers. (mro) Modified on 2/13/2017 (mro). (Entered: 02/13/2017)
LETTER MOTION for Local Rule 37.2 Conference addressed to Judge William H. Pauley, III from Defendants dated 02/10/2017. Document filed by Actavis Holdco U.S., Inc., Akorn, Inc., Fougera Pharmaceuticals, Inc., Hi-Tech Pharmacal Co., Inc., Morton Grove Pharmaceuticals, Inc., Perrigo Company PLC, Sandoz, Inc., Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals USA, Inc., Wockhardt USA LLC.(Serino, Joseph) (Entered: 02/10/2017)
MOTION for Leave to File Consolidated Amended Direct Purchaser Class Action Complaint UNDER SEAL . Document filed by FWK Holdings, L.L.C., Cesar Castillo, Inc..(Kaplan, Robert) (Entered: 02/10/2017)
MOTION to Seal Document Consolidated Amended End Payor Complaint. Document filed by Sergeants Benevolent Association Health & Welfare Fund.(Girard, Daniel) (Entered: 02/10/2017)
ORDER FOR ADMISSION PRO HAC VICE granting 28 Motion for Douglas J. Kurtenbach to Appear Pro Hac Vice. (Signed by Judge William H. Pauley, III on 2/8/2017) (cla) (Entered: 02/08/2017)
MOTION for Douglas J. Kurtenbach to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13288651. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Akorn, Inc., Hi-Tech Pharmacal Co., Inc.. (Attachments: # 1 Affidavit of Douglas J. Kurtenbach, # 2 Exhibit Certificate of Good Standing, # 3 Text of Proposed Order)Filed In Associated Cases: 1:16-mc-07229-WHP, 1:16-cv-07229-WHP(kurtenbach, douglas) (Entered: 02/07/2017)
AMENDED MASTER CASE ORDER NO. 1: The Clerk of Court is directed to open a master case docket titled In re Topical Corticosteroid Antitrust Litigation, bearing docket number 16-mc-7000, and file a copy of this Order on the docket. Any filing fees associated with opening the master case docket are waived. No attorney may file any document on the master case docket without the prior permission of this Court. Every pleading hereafter filed in the Consolidated Clobetasol Action shall bear the following caption, as further set out in the order. Every pleading hereafter filed in the Consolidated Desonide Action shall bear the following caption, as further set out in the order. Every pleading hereafter filed in the Consolidated Flucinonide Action shall bear the following caption, as further set out in the order. Each subsequent filing by the parties in 16-mc-7000, 16-mc-7229, 16-mc-7987, or 16-mc-8911, shall indicate whether the filing should be docketed in all related cases or only in specified related cases. Counsel are reminded that filings are to be spread across all related actions only when necessary. Interim Lead Counsel for End Payer Plaintiffs: This Court appoints Girard Gibbs LLP as Interim Lead Counsel for Plaintiffs in In re Clobetasol Antitrust Litigation, 16-mc-7229, In re Desonide Antitrust Litigation, 16-mc-7987, and In re Fluocinonide Antitrust Litigation, 16-mc-8911. The Court limits its appointment of Girard Gibbs LLP as Interim Lead Counsel for End Payor Plaintiffs to a one-year term. Counsel may apply for renewal by December 22, 2017. This Court will also entertain any competing applications at that time. Plaintiffs' counsel is directed to file consolidated amended complaints in 16-mc-7229, 16-mc-7987, and 16-mc-8911, by February 10, 2017. Defendants' Liaison Counsel, Kirkland & Ellis LLP, is directed to interpose an answer or file a letter request for a pre-motion conference addressed to the pleadings in 16-mc-7229, 16-mc-7987, and 16-mc-8911, no later than March 3, 2017. Plaintiffs' Interim Lead Counsel is directed to file any responsive letter no later than March 10, 2017. Any party wishing to raise other issues with this Court may file a letter no later than March 10, 2017 in 16-mc-7229, 16-mc-7987, or 16-mc-8911. This Court will conduct a conference concerning any proposed motions to dismiss and any other issues raised by the parties on March 21, 2017 at 11:00 a.m. Plaintiff Sergeants Benevolent Association Health & Welfare Fund's application for limited discovery is granted. All other discovery applications for limited discovery are denied at this time. Defendant Taro Pharmaceuticals Industries, Ltd. is directed to make an initial limited document production consisting of the September 8, 2016 subpoenas from the Department of Justice, Antitrust Division to Taro Pharmaceuticals Industries, Ltd. and its employees, together with any written responses and related communications between the Department of Justice and Taro Pharmaceuticals Industries, Ltd. by January 5, 2017. The Clerk of Court is directed to file this Order in 16mc7000, 16mc7229, 16mc7987, 16mc8911 and all related actions. To facilitate the spreading of text by this Court and counsel, the Clerk of Court may treat all of the related actions as consolidated for all purposes and to avoid the need to file a document separately in each case. (As further set out in the order) (Signed by Judge William H. Pauley, III on 2/3/2017) Filed In Associated Cases: 1:16-mc-07000-WHP et al.(cla) (Entered: 02/03/2017)
ORDER granting (25) Letter Motion for Extension of Time to Produce Expedited Discovery, and to Permit the Government to Intervene in case 1:16-mc-07229-WHP; granting (22) Letter Motion for Extension of Time to Produce Expedited Discovery, and to Permit the Government to Intervene in case 1:16-mc-07987-WHP; granting (21) Letter Motion for Extension of Time to Produce Expedited Discovery, and to Permit the Government to Intervene in case 1:16-mc-08911-WHP. Application granted. (Signed by Judge William H. Pauley, III on 1/25/2017) Filed In Associated Cases: 1:16-mc-07000-WHP, 1:16-mc-07229-WHP, 1:16-mc-07987-WHP, 1:16-mc-08911-WHP (cla) (Entered: 01/25/2017)
LETTER MOTION for Extension of Time to Produce Expedited Discovery, and to Permit the Government to Intervene addressed to Judge William H. Pauley, III from David N. Cinotti dated January 24, 2017. Document filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals USA, Inc..(Cinotti, David) (Entered: 01/24/2017)
JOINT LETTER addressed to Judge William H. Pauley, III dated 1/23/2017 re: coordination and consolidation of the direct purchaser claims for Clobetasol, Desonide and Fluocinonide matters. Document filed by Actavis Holdco U.S., Inc., Akorn, Inc., Fougera Pharmaceuticals, Inc., Hi-Tech Pharmacal Co., Inc., Morton Grove Pharmaceuticals, Inc., Perrigo Company PLC, Sandoz, Inc., Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals USA, Inc., Wockhardt USA LLC. (Attachments: # 1 Joint Proposed Amended Order, # 2 Joint Proposed Amended Order Redline)(Serino, Joseph) (Entered: 01/23/2017)
FILING ERROR - DEFICIENT DOCKET ENTRY (SEE 24 Letter) - LETTER addressed to Judge William H. Pauley, III dated January 23, 2017 re: the direct purchaser claims for Clobetasol, Desonide, and Fluocinonide. Document filed by Actavis Holdco U.S., Inc., Akorn, Inc., Fougera Pharmaceuticals, Inc., Hi-Tech Pharmacal Co., Inc., Morton Grove Pharmaceuticals, Inc., Novartis International AG, Perrigo Company PLC, Sandoz, Inc., Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals USA, Inc., Wockhardt USA LLC. (Attachments: # 1 Joint Proposed Amended Order, # 2 Joint Proposed Amended Order - Redline)(Serino, Joseph) Modified on 1/24/2017 (db). (Entered: 01/23/2017)
ORDER granting (19) Letter Motion for Extension of Time to Produce Expedited Discovery in case 1:16-mc-07229-WHP; granting (16) Letter Motion for Extension of Time to Produce Expedited Discovery in case 1:16-mc-07987-WHP; granting (14) Letter Motion for Extension of Time to Produce Expedited Discovery in case 1:16-mc-08911-WHP. Application granted. The Clerk of Court is directed to file this Order in all consolidated actions. (Signed by Judge William H. Pauley, III on 1/11/2017) Filed In Associated Cases: 1:16-mc-07000-WHP et al. (cla) (Entered: 01/11/2017)
LETTER MOTION for Extension of Time to Produce Expedited Discovery addressed to Judge William H. Pauley, III from Daniel C. Girard dated January 10, 2017. Document filed by A.F. of L. - A.G.C Building Trades Welfare Plan, International Union of Operating Engineers Local 30 Benefits Fund, NECA-IBEW Welfare Trust Fund, Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund, Sergeants Benevolent Association Health & Welfare Fund, St. Paul Electrical Workers' Health Plan, UFCW Local 1500 Welfare Fund, United Food and Commercial Workers Unions and Employers Midwest Health Benefits Fund.(Girard, Daniel) (Entered: 01/10/2017)
NOTICE OF APPEARANCE by Adam E Polk on behalf of A.F. of L. - A.G.C Building Trades Welfare Plan, International Union of Operating Engineers Local 30 Benefits Fund, NECA-IBEW Welfare Trust Fund, Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund, Sergeants Benevolent Association Health & Welfare Fund, St. Paul Electrical Workers' Health Plan, UFCW Local 1500 Welfare Fund, United Food and Commercial Workers Unions and Employers Midwest Health Benefits Fund. (Polk, Adam) (Entered: 01/06/2017)
NOTICE OF APPEARANCE by Adam E Polk on behalf of A.F. of L. - A.G.C Building Trades Welfare Plan, International Union of Operating Engineers Local 30 Benefits Fund, NECA-IBEW Welfare Trust Fund, Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund, Sergeants Benevolent Association Health & Welfare Fund, St. Paul Electrical Workers' Health Plan, UFCW Local 1500 Welfare Fund, United Food and Commercial Workers Unions and Employers Midwest Health Benefits Fund. (Polk, Adam) (Entered: 01/06/2017)
NOTICE OF APPEARANCE by Daniel Charles Girard on behalf of A.F. of L. - A.G.C Building Trades Welfare Plan, International Union of Operating Engineers Local 30 Benefits Fund, NECA-IBEW Welfare Trust Fund, Plumbers & Pipefitters Local 178 Health & Welfare Trust Fund, Sergeants Benevolent Association Health & Welfare Fund, St. Paul Electrical Workers' Health Plan, UFCW Local 1500 Welfare Fund, United Food and Commercial Workers Unions and Employers Midwest Health Benefits Fund. (Girard, Daniel) (Entered: 01/06/2017)
MASTER CASE ORDER No. 2: By letter dated January 3, 2017, Defendants Taro Pharmaceutical Industries, Ltd. and Taro Pharmaceuticals U.S.A., Inc. ("Taro") request an extension of time to produce documents as required in paragraph 22 of Master Case Order No. 1. Plaintiffs consent to the Taro's request. Accordingly, this Court grants the requested extension of time to January 12, 2017. (Signed by Judge William H. Pauley, III on 1/5/2017) (cla) (Entered: 01/05/2017)
LETTER addressed to Judge William H. Pauley, III from Joseph Serino, Jr. dated 01/05/2017 re: Nomination of Defendants Liaison Counsel. Document filed by Akorn, Inc., Hi-Tech Pharmacal Co., Inc.. (Attachments: # 1 SCHEDULE OF DEFENDANTS)(Serino, Joseph) (Entered: 01/05/2017)
NOTICE OF APPEARANCE by Danielle Foley on behalf of Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals USA, Inc.. (Foley, Danielle) (Entered: 01/04/2017)
NOTICE OF APPEARANCE by Lisa Jose Fales on behalf of Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals USA, Inc.. (Fales, Lisa) (Entered: 01/04/2017)
NOTICE OF APPEARANCE by David Neil Cinotti on behalf of Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals USA, Inc.. (Cinotti, David) (Entered: 01/04/2017)
NOTICE OF APPEARANCE by James Douglas Baldridge on behalf of Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals USA, Inc.. (Baldridge, James) (Entered: 01/04/2017)
NOTICE OF APPEARANCE by William Alfred Escobar on behalf of Morton Grove Pharmaceuticals, Inc., Wockhardt USA LLC. (Escobar, William) (Entered: 01/03/2017)
LETTER MOTION for Extension of Time to Produce Expedited Discovery addressed to Judge William H. Pauley, III from David N. Cinotti dated January 3, 2017. Document filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals USA, Inc..(Cinotti, David) (Entered: 01/03/2017)
MASTER CASE ORDER No. 1: The Clerk of Court is directed to open a master case docket titled In re Topical Corticosteroid Antitrust Litigation, bearing docket number 16-mc-7000, and file a copy of this Order on the docket. Any filing fees associated with opening the master case docket are waived. No attorney may file any document on the master case docket without the prior permission of this Court. All Clobetasol allegations and claims for relief in the above-captioned actions, and any allegations or claims for relief relating to Clobetasol in any later-filed actions, shall be consolidated for coordinated pre-trial proceedings pursuant to Rule 42(a) of the Federal Rules of Civil Procedure in an action titled In re Clobetasol Antitrust Litigation, bearing docket number 16-mc-7229. Any filing fees associated with opening the In re Clobetasol Antitrust Litigation docket are waived. All Desonide allegations and claims for relief in the above-captioned actions, and any allegations or claims for relief relating to Desonide in any later-filed actions, shall be consolidated for coordinated pre-trial proceedings pursuant to Rule 42(a) of the Federal Rules of Civil Procedure in an action titled In re Desonide Antitrust Litigation, bearing docket number 16-mc-7987. Any filing fees associated with opening the In re Desonide Antitrust Litigation docket are waived. All Fluocinonide allegations and claims for relief in the above-captioned actions, and any allegations or claims for relief relating to Fluocinonide in any later-filed actions, shall be consolidated for coordinated pre-trial proceedings pursuant to Rule 42(a) of the Federal Rules of Civil Procedure in an action titled In re Fluocinonide Antitrust Litigation, bearing docket number 16-mc-8911. Any filing fees associated with opening the In re Fluocinonide Antitrust Litigation docket are waived. Interim Lead Counsel for Plaintiffs: This Court appoints Girard Gibbs LLP as Interim Lead Counsel for Plaintiffs in In re Clobetasol Antitrust Litigation, 16-mc-7229, In re Desonide Antitrust Litigation, 16-mc-7987, and In re Fluocinonide Antitrust Litigation, 16-mc-8911. Plaintiffs' Interim Lead Counsel is directed to file consolidated amended complaints in 16-mc-7229, 16-mc-7987, and 16-mc-8911, by February 10, 2017. Defendants' Liaison Counsel are directed to interpose an answer or file a letter request for a pre-motion conference addressed to the pleadings in 16-mc-7229, 16-mc-7987, and 16-mc-8911, no later than March 3, 2017. Plaintiffs' Interim Lead Counsel is directed to file any responsive letter no later than March 10, 2017. This Court will conduct a conference concerning any proposed motions to dismiss and any other issues raised by the parties on March 21, 2017 at 11:00 a.m. Plaintiff Sergeants Benevolent Association Health & Welfare Fund's application for limited discovery is granted. All other discovery applications for limited discovery are denied at this time. Defendant Taro Pharmaceuticals Industries, Ltd. is directed to make an initial limited document production consisting of the September 8, 2016 subpoenas from the Department of Justice, Antitrust Division to Taro Pharmaceuticals Industries, Ltd. and its employees, together with any written responses and related communications between the Department of Justice and Taro Pharmaceuticals Industries, Ltd. by January 5, 2017. The Clerk of Court is directed to file this Order in 16mc7000, 16mc7229, 16mc7987, 16mc8911 and all related actions. To facilitate the spreading of text by this Court and counsel, the Clerk of Court may treat all of the related actions as consolidated for all purposes and to avoid the need to file a document separately in each case. (As further set out in the order) (Amended Pleadings due by 2/10/2017., Status Conference set for 3/21/2017 at 11:00 AM before Judge William H. Pauley III.) (Signed by Judge William H. Pauley, III on 12/22/2016) (cla) Modified on 12/23/2016 (cla). (Entered: 12/23/2016)
Third party AI contribution in government documents
Possible
Document content is reproduced directly from government sources. Some filings in our database may themselves contain AI-generated content submitted by third parties to government agencies.
Update
Alerts
